ライフサイエンスコーパス: plasma level

1 th very limited brain exposure (1/190 of the plasma level).

2 with IgG(4)-RD and correlate with galectin-3 plasma levels.

3 e, low-fat diet reduced FGF21 expression and plasma levels.

4 that CT exhibits a long-term effect on miRNA plasma levels.

5 xpression on neutrophils and myeloperoxidase plasma levels.

6 ents cured with increasing quartiles of ASOX plasma levels.

7 red a strong correlation between FX and PTX2 plasma levels.

8 001), T3t/T4t (P = .001), and TSH (p = .001) plasma levels.

9 Tissue expression of miR-181a-5p reflected plasma levels.

10 and their expression correlated with CXCL10 plasma levels.

11 novel genetic loci regulating FVIII and VWF plasma levels, 10 of which we validated functionally.

12 600-IL-1Ra displayed markedly extended blood plasma levels 3 days post-administration, whereas anakin

13 Data acquisition commenced 2 h (peak plasma levels) after a single oral dose of 600 mg CBD or

14 The relationships between sST2 plasma level and outcome measures were assessed in both

15 y in the human brain, and that both psilocin plasma levels and 5-HT2AR occupancy are closely associat

16 Associations between biomarker plasma levels and incident all-cause and Alzheimer's dis

17 We suggest an association between high ASOX plasma levels and increased antiparasitic efficacy in pa

18 penumbra, higher tumor necrosis factor alpha plasma levels and lower peripheral blood mononuclear cel

19 sulted in increased alanine aminotransferase plasma levels and NGAL expression.

20 used to detect interactions between hormonal plasma levels and ocular parameters.

21 Moreover, biomarker plasma levels and rates of change over time of participa

22 deduced fractional excretion using reported plasma levels and urinary and plasma creatinine estimate

23 Setting intraclot zymogen concentrations to plasma levels (and neglecting cofactor rate limitations)

24 Nicotine plasma levels, and no group differences in effects of ni

25 y shows that low amyloid-beta42 and high NfL plasma levels are each independently and in combination

26 Interestingly, their respective plasma levels are interdependent.

27 odulatory properties, was tested because its plasma levels are lowered in obesity.

28 Moreover, soluble IL-27 plasma levels are negatively associated with the breadth

29 into a clinical setting, we show that AnxA1 plasma levels are reduced in human and murine stroke and

30 ypeptide 1 (CYP7B1) and results in increased plasma levels, as well as fecal excretion, of bile acids

31 metabolites of mitochondrial oxidation whose plasma levels associate with metabolic diseases.

32 L shedding from T cells and increased sCD62L plasma levels at CML diagnosis on molecular response to

33 MA delivers active pharmaceutical ingredient plasma levels comparable to those achieved with subcutan

34 I-deficient mice, 5-OHTrp(72) apoA-I reached plasma levels comparable with those of native apoA-I yet

35 FEP had reduced GABA plasma levels compared to siblings and controls (p < 0.0

36 macrophages, while having no effect on their plasma levels compared to the PBS control.

37 In drug-induced acute liver failure, plasma levels correlate with outcome.

38 igher CHADS(2) scores, and higher dabigatran plasma levels despite more frequent use of lower-dose da

39 ients and unaffected carriers showed that FH plasma levels determined by the nonmutated chromosome mo

40 DNA sequences and therapeutic antiretroviral plasma levels did not support HIV replication as the cau

41 We hypothesized that high ASOX plasma levels during albendazole therapy may be associat

42 mine and HVA+DOPAC/dopamine) changed with E2 plasma levels, except for high PAH/low PFAS and low PAH/

43 nical and clinical reports of increased CCL2 plasma levels following in vivo administration of CCR2 a

44 s, and achievement of Exenatide steady-state plasma levels from day 10-28.

45 Concomitant high vancomycin trough plasma levels had been observed in each patient.

46 -negative disease mechanisms affecting C1INH plasma levels in HAE type I patients, and may pave the w

47 Cabotegravir plasma levels in macaques dropped below detectable level

48 ce, and also found substantially higher CCL2 plasma levels in mice lacking the CCR2 gene.

49 Finally, we confirmed low 25D plasma levels in patients with IBD with active inflammat

50 d (CSF) levels of FGLs correlated with blood plasma levels in rats and non-human primates, and CSF-to

51 The 10-fold lower DMXB-A plasma levels in smokers suggest that chronic smoking en

52 In acute inflammation, SAA plasma levels increase ~1,000 fold, suggesting that this

53 nalyses of biomarkers revealed that mean NfL plasma levels increased 3.4 times faster in participants

54 variant had significantly elevated TGF-beta1 plasma levels (median, 23 376.49 vs 18 476.52 pg/mL; P =

55 uced pulmonary inflammation and elevation of plasma level of interferon-beta and -gamma and interleuk

56 Plasma level of syndecan-1 was increased in hyperuricemi

57 a potent inhibitor of OATP2B1, decreased the plasma level of the OATP2B1 substrate fexofenadine, sugg

58 with variable viral loads and measuring the plasma levels of >600 soluble proteins, our data highlig

59 y subjects using colon delivery capsules and plasma levels of (13) C-SCFAs (13) C-glucose, (13) C-cho

60 tyl)benzoic acid, 12, provided 5-fold higher plasma levels of 1 compared to oral administration of 1

61 s the only prodrug that achieved substantial plasma levels of 1.

62 Plasma levels of 1305 proteins were related to echocardi

63 8; 95% CI, 1.56-3.85; P < 0.001), and higher plasma levels of 16-alpha-hydroxyestradiol (OR per 1-ln

64 Plasma levels of 17 cytokines were screened in the same

65 cute phase was significantly correlated with plasma levels of 17beta-estradiol (E2).

66 t a pharmacokinetic-adjusted dose (targeting plasma levels of 200 or 500 ng/ml), or placebo for 16 we

67 rols had no significant differences in their plasma levels of 38 inflammatory cytokines/chemokines me

68 KD), we assessed the association of baseline plasma levels of 4 inflammatory markers (interleukin-6 (

69 re, we investigated the associations between plasma levels of 90 neurology-related proteins (Olink(R)

70 malnutrition with therapeutic foods reduced plasma levels of a biomarker of osteoclastic activity wi

71 ID patients displayed significantly elevated plasma levels of a marker of neutrophil activation neutr

72 Plasma levels of a number of neurology-related proteins

73 Plasma levels of ACTH and CORT did not differ between th

74 Plasma levels of ADEs were decreased after acute sTBI an

75 On the other hand, plasma levels of adiponectin are decreased in such metab

76 However, plasma levels of adiponectin have been shown to inversel

77 We tested the association of rs72613567 with plasma levels of alanine transaminase (ALT) and clinical

78 Plasma levels of albendazole sulfoxide (ASOX), the activ

79 C cleavage were independent of the increased plasma levels of aldosterone.

80 In addition, plasma levels of AlkP, high-density lipoprotein (HDL), t

81 o inhibit neutrophil degranulation decreased plasma levels of alpha-defs, caused a phenotypic reversi

82 Plasma levels of alpha-fetoprotein and c-MET were associ

83 nfr1(-/-)/Mdr2(-/-) mice displayed increased plasma levels of ALT, ALP, and bilirubin as well as a si

84 he liver, which was associated with elevated plasma levels of aminotransferases.

85 Median plasma levels of APC increased more (P=0.008) in FVL car

86 ApoC-III inhibition by volanesorsen reduced plasma levels of apoC-II, apoC-III, triacylglycerols, an

87 Plasma levels of arginine, citrulline, ornithine, asymme

88 Transplantation trial, we determined whether plasma levels of B-type natriuretic peptide (BNP) and ca

89 Plasma levels of B-type natriuretic peptide, hs-TnI (hig

90 fection and is usually assessed by measuring plasma levels of bacterial lipopolysaccharide (LPS).

91 e cardiomyocyte death and fibrosis and lower plasma levels of biomarkers of cardiac damage (high-sens

92 Plasma levels of BMP9 and antagonist soluble endoglin we

93 et of patients with PAH had markedly reduced plasma levels of BMP9 and BMP10 in the absence of GDF2 m

94 ho carried these mutations exhibited reduced plasma levels of BMP9 and reduced BMP activity.

95 Prior to treatment, baseline plasma levels of both unmodified and S-glutathionylated

96 sed the risk of breast cancer with regard to plasma levels of c-peptide, gastric inhibitory polypepti

97 Elevated preoperative and postoperative plasma levels of C-reactive protein were associated with

98 ation changes at these sites correlated with plasma levels of C-reactive protein.

99 dy, we evaluated the association of baseline plasma levels of C-terminal FGF23 with time to first hos

100 d markedly higher and enduring post-baseline plasma levels of C1-INH functional activity and C1-INH a

101 Reduced plasma levels of C1INH lead to enhanced activation of th

102 Our data showed a significant increase in plasma levels of CCL18 in HIV-1-infected individuals com

103 This study shows associations of higher plasma levels of Cer-16 and SM-16 with increased risk of

104 We examined the plasma levels of chemokines in individuals with PTB, lat

105 f lanadelumab was assessed by measurement of plasma levels of cleaved high-molecular-weight kininogen

106 Plasma levels of complement C5 were analyzed in relation

107 Plasma levels of complement proteins correlated with res

108 Twenty-one days of CUS decreased basal plasma levels of corticosterone and produced a shorter l

109 Plasma levels of cortisol and chromogranin-A were determ

110 During the first week of life the elevated plasma levels of CRP predicted the risk of BPD (OR 3.4,

111 e, and a decrease in recipient postoperative plasma levels of CXCL10 (C-X-C motif chemokine 10), inte

112 We determined the plasma levels of CysC and NGAL in 429 patients hospitali

113 Plasma levels of cytokeratin-18 fragments are reliable n

114 n and left ventricular function, and reduced plasma levels of cytokines (interleukin 6, granulocyte c

115 Secondary endpoints included alveolar and plasma levels of cytokines and soluble form of the recep

116 s (1.5 g/kg on day 1 and 1 g/kg on day 3) on plasma levels of cytokines in biobanked samples from 78

117 iocirculatory function, portal pressure, and plasma levels of cytokines, collecting data from 18 pati

118 given albumin had significant reductions in plasma levels of cytokines.

119 = 2.04; 95% CI, 1.16-3.57; P = 0.01), lower plasma levels of dehydroepiandrosterone-sulfate (OR per

120 holipid form may provide a means to increase plasma levels of DHA-lysoPC, thereby decreasing the risk

121 Also, appreciable plasma levels of DHE were seen within 5min for both deli

122 renal clearance might lead to subtherapeutic plasma levels of drugs with predominant renal clearance.

123 the association of genetic variants with the plasma levels of each of the 156 Framingham Cardiovascul

124 Results showed maternal plasma levels of eicosanoids and fatty acids generally f

125 After adjusting for confounders, plasma levels of elastin degraded by proteinase 3 and ca

126 All hemodialysis patients showed higher plasma levels of endothelial-derived EV than healthy sub

127 Circulating tumor cells (CTCs) and plasma levels of Epstein-Barr virus (EBV) DNA are sensit

128 At the same consultations blood plasma levels of estradiol (E2) and thyroid hormones (TS

129 nitial release burst, generated steady-state plasma levels of Exenatide, but with PT320 producing con

130 y with the demonstration that an increase in plasma levels of FABP4 is inhibited by chloroquine treat

131 associations between this haplotype and the plasma levels of factors such as TGF-b, S100B, sRAGE and

132 ers have hypertriglyceridaemia and increased plasma levels of fatty acids, which are taken up and sto

133 Therefore, plasma levels of FB, Bb, and terminal complement complex

134 perphosphaturic responses and changes in the plasma levels of FGF23 and PTH.

135 In a subcohort (n=131) we also measured plasma levels of FGF23, calcium, phosphate, parathyroid

136 with increased liver expression and elevated plasma levels of fibroblast growth factor 21 (FGF21), a

137 Plasma levels of fitusiran increased in a dose-dependent

138 KD), we assessed the association of baseline plasma levels of four inflammatory markers (interleukin-

139 is a highly regulated process that maintains plasma levels of free fatty acids to supply energy to ce

140 people living with HIV (PLWH) have increased plasma levels of fungal polysaccharide (1->3)-beta-D-Glu

141 functional human FVIII, leading to increased plasma levels of FVIII and restoration of blood clotting

142 Maximum plasma levels of GEN were dose-dependent and ranged betw

143 atients showed significantly greater fasting plasma levels of glucose and insulin and HOMA-IR, and po

144 Plasma levels of glutamic acid (GLU), glutamine, glycine

145 All plasma levels of glycemia measured by enzymatic techniqu

146 We sought to determine whether plasma levels of glycogen phosphorylase BB (GPBB) isofor

147 erent compared with adults; at the same time plasma levels of haemostatic proteins vary considerably

148 Plasma levels of HBV DNA were quantified by PCR reaction

149 We measured plasma levels of hemoglobin A1c, glucose, insulin, gluca

150 Plasma levels of hemopexin, which were decreased in wome

151 In addition, plasma levels of Hexokinase 1 and Ras differ between FXS

152 Plasma levels of high-density lipoprotein cholesterol (H

153 g human B-1 cells positively associates with plasma levels of IgM antibodies specific for malondialde

154 , Tnfa, and Crp expression in WBCs, elevated plasma levels of IL-1beta, IL-6, and IL-8, increased IL-

155 e unaltered by 11beta-HSD1 deficiency though plasma levels of IL-4, IL-6 and TNF-alpha were slightly

156 Thus, higher plasma levels of IL-6 and TNF-alpha, but not IL-1RA or T

157 sion of T-cell activation markers and higher plasma levels of IL-6 than did healthy ANA+ European Ame

158 Rosuvastatin not alter plasma levels of IL-6, soluble (s)TNF-RII, CXCL10, sCD14

159 easuring changes in immune cell frequencies, plasma levels of immune mediators, and differentially ex

160 We compared plasma levels of immunoglobulins, C. neoformans glucuron

161 ociated (FDR corrected p < 0.05) with higher plasma levels of inflammatory chemokines.

162 ted in a significant decrease of retinal and plasma levels of inflammatory cytokines and adhesion fac

163 Decreased plasma levels of inflammatory cytokines in ApoE(-/-)MHCI

164 risingly, systemic DPP4 inhibition increases plasma levels of inflammatory markers in regular chow-fe

165 At day 1, clinical score and plasma levels of inflammatory mediators were increased i

166 By contrast, we detected enhanced plasma levels of inflammatory mediators-including EN-RAG

167 Male patients had higher plasma levels of innate immune cytokines such as IL-8 an

168 After the last session, plasma levels of insulin, leptin, amylin, and glucagon-l

169 Plasma levels of interleukin 8 (IL8), IL13, chemokine (C

170 Plasma levels of isoproterenol at each increment were me

171 tes CXCR5 on circulating ILC3s and increases plasma levels of its ligand, CXCL13, in humans.

172 lyx damage during I/R is evidenced by rising plasma levels of its principal constituents, heparan sul

173 s was not readily explained by variations in plasma levels of key fibrinolytic proteins.

174 Higher plasma levels of KIM-1, TNFR-1, TNFR-2, MCP-1, suPAR, an

175 g peripheral artery tonometry (EndoPAT), and plasma levels of l-arginine, arginase-1, and asymmetric

176 rocytes in peripheral blood smear, increased plasma levels of lactate dehydrogenase activity, blood u

177 an obese phenotype and caused an increase in plasma levels of leptin, IL-6 and TNFalpha.

178 ibited distinct patterns of association with plasma levels of lipids and liver enzymes, respectively.

179 dividual gallstone loci were associated with plasma levels of lipids, lipoproteins, and liver enzymes

180 videnced by global ADC decrease and elevated plasma levels of lipocalin-2 and microRNA-150, was assoc

181 LA-DR+CD8+ (activated) T-cell frequency, and plasma levels of lipopolysaccharide (LPS), LPS binding p

182 contemporary general population study, high plasma levels of lipoprotein(a) were associated with inc

183 Finally, Ss+ was also associated with higher plasma levels of matrix metalloproteinases ([MMP]-1, -2,

184 oavailability approaches 100% with sustained plasma levels of memantine over seven days and profiles

185 INF individuals exhibit significantly higher plasma levels of microbial translocation markers (LPS, s

186 dition, CC genotype carriers had the highest plasma levels of MIF than other genotype carriers.

187 Pretreatment plasma levels of miR-301a-3p and miR-145-5p were higher

188 Our data also demonstrate enhanced plasma levels of MMPs in coinfected individuals, suggest

189 -specific T-cell responses and directly with plasma levels of molecules involved in Wnt/beta-catenin

190 We analyzed plasma levels of myeloperoxidase (a marker of neutrophil

191 Plasma levels of natriuretic peptides have proven to be

192 Increased plasma levels of NETs, tissue factor (TF) activity, and

193 mouse models, with increases in brain and/or plasma levels of neurotoxic TNFalpha and several other p

194 We found that plasma levels of o,p'-DDT and p,p'-DDT were independentl

195 Low plasma levels of oxytocin (OT) have also been found in A

196 two cohorts and tested the effects of OC on plasma levels of oxytocin, adrenocorticotropic hormone (

197 he Stellarex DCB in comparison with PTA, and plasma levels of paclitaxel fall to low levels within 1

198 ther basophil activation in whole blood, and plasma levels of peanut-specific immunoglobulins, are us

199 d systemic inflammation, including increased plasma levels of pentraxin-2 and activated antigen-prese

200 To compare the circulating plasma levels of peptide YY and ghrelin in control subje

201 TXRF detected significantly increased plasma levels of phosphorus (p = 1.33 x 10(-12)) and cal

202 ue of the JCI, Mani and colleagues show that plasma levels of plasma liver-enriched antimicrobial pep

203 Plasma levels of PPi and the degree of ectopic mineraliz

204 eatic ductal adenocarcinoma (PDAC) have high plasma levels of PRL.

205 oms, including IR, by markedly elevating the plasma levels of pro-inflammatory cytokines, including I

206 We measured plasma levels of procollagen type 1 N-terminal propeptid

207 n and puncture-induced sepsis, decreases the plasma levels of proinflammatory cytokines and organ inj

208 Urinary and plasma levels of protein S, sTyro3, sAxl, and sMer were

209 Associations between plasma levels of proteins and miRNAs and response to tre

210 elic effects, cerebral 5-HT2AR occupancy and plasma levels of psilocin in humans.

211 prospectively examined associations between plasma levels of purine metabolites with T2D risk and th

212 patients had intense and reversible peaks in plasma levels of renin and interleukin 6.

213 Plasma levels of RvD1 (mg/dL) were reduced in patients w

214 We identified elevated plasma levels of S-glutathionylated serpin A1 monomer, t

215 tissue plasminogen activator levels but high plasma levels of S100A10.

216 prothrombinase and a further ~3-4-fold when plasma levels of S195A prothrombin were present (k(a) ((

217 We analyzed whether plasma levels of sCD40L and sCD40R predict changes in re

218 Plasma levels of sDPP4 and biomarkers of inflammation ar

219 Prolonged DPP4 inhibition increases plasma levels of sDPP4, and induces sDPP4 expression in

220 dvanced magnetic resonance imaging (MRI) and plasma levels of select proteins were examined here in a

221 SCA individuals had significantly increased plasma levels of serotonin (5-HT), and serotonin molecul

222 A case-control study compared plasma levels of several inflammatory biomarkers from ne

223 In the derivation cohort, increased plasma levels of short- and medium-chain acylcarnitines

224 Increased plasma levels of soluble CD25, interleukin (IL)-6, IL-1b

225 Plasma levels of soluble factors associated with inflamm

226 d regression model analysis demonstrate that plasma levels of soluble interleukin-27 (IL-27) are sign

227 nsion of the CD8 T cell compartment and with plasma levels of soluble mediators of antiviral immunity

228 Plasma levels of soluble membrane-bound ST2 (ST2) are el

229 Stenosis application increased plasma levels of soluble P-selectin in wild-type but not

230 etanercept treatment normalised the elevated plasma levels of some cytokines.

231 no significant effect of SVR was observed in plasma levels of sRANKL (P=0.205), OPG (P=0.249), and sR

232 ome (ICU treatment) was associated with high plasma levels of sTIM-3 and myeloperoxidase, suggesting

233 We measured plasma levels of suPAR preprocedurally in patients who u

234 cells in RIC mice and elevated blood and BM plasma levels of T helper1 cytokines.

235 Plasma levels of tau phosphorylated at threonine-217 (p-

236 biota from young and older mice and measured plasma levels of the adverse gut-derived metabolite trim

237 associated with gut dysbiosis and increased plasma levels of the adverse gut-derived metabolite trim

238 of the trial was to assess whether extending plasma levels of the alpha7-nicotinic acetylcholine rece

239 Plasma levels of the antigen of interest were also deter

240 ID was found to be associated with increased plasma levels of the B-cell-attracting chemokine CXCL13.

241 Plasma levels of the Bb fragment showed a similar patter

242 Additionally, there were elevations in plasma levels of the beneficial lipoprotein biomarkers H

243 This was associated with a reduction in plasma levels of the clinical biomarker of cardiac injur

244 In many patients, plasma levels of the DHD metabolites were found to excee

245 Plasma levels of the inflammatory cytokine tumor necrosi

246 p = 0.02) upon the second challenge, whereas plasma levels of the key antiinflammatory cytokine inter

247 Lower plasma levels of the oxysterol cholestenoic acid associa

248 ted and HIV plus dengue-coinfected patients, plasma levels of the platelet-derived chemokines RANTES/

249 a novel positive association between VAT and plasma levels of the potential pharmacological agent pip

250 Elevated plasma levels of the protein have been linked to diabete

251 Plasma levels of the proteins, CDH6 (beta = 0.638, P = 3

252 ocytes (31.7% vs 24.7%, P = .01), and higher plasma levels of the soluble CD163 scavenger receptor (0

253 d monocytes, accompanied by locally elevated plasma levels of the T-cell chemoattractant CXCL-11.

254 Notably, plasma levels of the TH2 chemokines CCL17 and CCL22 are

255 itol is of medical interest because elevated plasma levels of this polyol are predictive for visceral

256 Changes in plasma levels of thrombin, prothrombin activation fragme

257 irectly transported, the Oat3KO had elevated plasma levels of TMAO, which is associated with cardiova

258 Plasma levels of total cholesterol (T-CHL), low density

259 olerance, insulin sensitivity, and decreases plasma levels of triglycerides.

260 nt significantly reduced the heart recipient plasma levels of troponin T by 34% (14 900 +/- 12 100 ng

261 study, we observed a significant increase of plasma levels of TRX80 in old subjects compared with hea

262 y day 360 in abstinent AH patients; however, plasma levels of tumor necrosis factor alpha, IL-8, IL-1

263 alicylic acid treatment resulted in enhanced plasma levels of tumor necrosis factor-alpha (+53%; p =

264 No changes in plasma levels of very low-density lipoprotein/low-densit

265 We identify reduced plasma levels of von Willebrand factor (VWF) and reduced

266 Basal plasma levels of von Willebrand factor and recruitment o

267 ated by the patient with undetectable trough plasma levels of voriconazole.

268 , which have been previously associated with plasma levels of VWF and FVIII, were associated with the

269 Moreover, we observed reduced plasma levels of zinc-alpha-2-glycoprotein, butyrylcholi

270 After activation of plasma, levels of the most potent form of chemerin, chem

271 ied to test the causal role of FVIII and VWF plasma levels on the risk of arterial and venous thrombo

272 ent with therapeutically relevant isradipine plasma levels, or Cav1.3 LTCC deficiency in 6-OHDA-treat

273 E2 plasma levels (p = .092) and time period of measurement

274 Moreover, in the PESA study, C5 plasma levels positively correlated with global plaque v

275 endothelial (HMEC-1) cell assay, reduced FH plasma levels produced by the nonmutated chromosome corr

276 Our data also showed that plasma levels rather than fecal levels of short-chain fa

277 a dose which recapitulates stressor-induced plasma levels, reproduced stress-potentiated cocaine-pri

278 CELA2A plasma levels rise postprandially and parallel insulin l

279 d zeaxanthin dietary supplementation despite plasma levels showing continuous exposure to lutein and

280 ly 21-day circulating IgG half-life and high plasma levels; similarly, FcRn recycles albumin and is t

281 availability, and achieving circulating free plasma levels that provided near maximal CGRP receptor c

282 y a central role in maintaining high albumin plasma levels through a cellular recycling pathway.

283 newly-developed proguanylin assay, we found plasma levels to be raised in humans after total gastrec

284 ive, population-based study and relate their plasma levels to risk of CVD.

285 A log2 higher baseline amyloid-beta42 plasma level was associated with a lower risk of develop

286 In the systematic TDM arm, AED plasma levels were available at each appointment, wherea

287 REG3alpha plasma levels were compared with HIV disease progression

288 s were carried out on hairless rats, and DHE plasma levels were determined by liquid chromatography-t

289 TRX1 and TRX80 plasma levels were determined with a specific ELISA.

290 erimental findings, baseline myeloperoxidase plasma levels were independently associated with a histo

291 ASOX plasma levels were measured at treatment day 7 in 118 pa

292 d transforming growth factor beta (TGF-beta) plasma levels were measured in 22 pediatric patients wit

293 AG10 plasma levels were measured.

294 Plasma levels were obtained 2.5 h post administration.

295 um correlated highly (p<0.0001 for all), but plasma levels were only 76.9% of paired serum concentrat

296 In patients with CHD, 15d-PGJ(2) plasma levels were significantly upregulated compared wi

297 Moreover, MCAM was effective at times when plasma levels were very low, suggesting that pharmacodyn

298 tic plaques and is reflected by increased C5 plasma levels, which have promising value as a novel cir

299 The relationships between increasing ASOX plasma levels with the proportion of cysts resolved and

300 expression, and an increase in endothelin-1 plasma levels, with all mice dying within 5 wk.